Original language | English |
---|---|
Pages (from-to) | 158-166 |
Number of pages | 9 |
Journal | Neuromuscular Disorders |
Volume | 31 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2021 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Neuromuscular Disorders, Vol. 31, No. 2, 02.2021, p. 158-166.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - 246th ENMC International Workshop
T2 - Protein aggregate myopathies 24–26 May 2019, Hoofddorp, The Netherlands
AU - ENMC workshop study group
AU - Olivé, Montse
AU - Winter, Lilli
AU - Fürst, Dieter O.
AU - Schröder, Rolf
AU - Behin, Anthony
AU - Breukel, Alexandra
AU - Brumhard, Matthias
AU - Bryson-Richardson, Robert
AU - Claeys, Kristl
AU - Ferreiro, Ana
AU - Fürst, Dieter
AU - Goebel, Hans H.
AU - Gupta, Vandana
AU - Kley, Rudolf
AU - Mankodi, Ami
AU - Noguchi, Satoru
AU - Oldfors, Anders
AU - Selcen, Duygu
AU - Timmerman, Vincent
AU - Udd, Bjarne
AU - Walter, Maggie
AU - Weihl, Conrad
AU - Wiche, Gerhard
AU - Winter, Lilly
N1 - Funding Information: This workshop was made possible by the financial support of the European Neuromuscular center (ENMC) and ENMC main sponsors: Funding Information: This workshop was made possible by the financial support of the European Neuromuscular center (ENMC) and ENMC main sponsors:, ? Association Fran?aise contre les Myopathies (France), ? Deutsche Gesellschaft f?r Muskelkranke (Germany), ? Telethon Foundation (Italy), ? Muscular Dystrophy Campaign (UK), ? Muskelsvindfonden (Denmark), ? Prinses Beatrix Spierfonds (The Netherlands), ? Schweizerische Stiftung f?r die Erforschung der Muskelkrankheiten (Switzerland), ? Spierziekten Nederland (The Netherlands), and Associated members:, ? ?sterreichische Muskelforschung (Austria), ? Finnish Neuromuscular Association (Finland), With a special thanks to the members of the ENMC company Forum:, ? Sanofi Genzyme, ? Santhera Pharmaceuticals, ? Amicus Therapeutics, ? CSL Behring LLC, ? Ionis Pharmaceuticals, ? Perkin Elmer/Wallac Oy, ? AveXis Switzerland GmbH, ? Biogen International GmbH, ? Hoffmann-la-Roche
PY - 2021/2
Y1 - 2021/2
UR - http://www.scopus.com/inward/record.url?scp=85097780374&partnerID=8YFLogxK
U2 - 10.1016/j.nmd.2020.11.003
DO - 10.1016/j.nmd.2020.11.003
M3 - Article
C2 - 33303357
AN - SCOPUS:85097780374
SN - 0960-8966
VL - 31
SP - 158
EP - 166
JO - Neuromuscular Disorders
JF - Neuromuscular Disorders
IS - 2
ER -